Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis

Diana Girnita, MD, PhD, & Vishnuteja Devalla, MD  |  Issue: June 2018  |  June 21, 2018

Based on his presentation, an autoimmune and vasculitis work-up was initiated. Markers of inflammation were elevated (ESR 40.8 mm/hr, upper limited of normal (ULN)< 10mm/hr, CRP 43, ULN <10mg/L), the ANA and subset serology (including dsDNA, SSA/SSB, RNP, Sm) were negative. Complement levels were normal. Urinalysis was normal with no signs of proteinuria, hematuria or casts. ANCA antibodies came back positive (titer 1:230, Ref < 1.20 AI), with a positive PR3 antibody (titer 5.3, ULN <1.0 AI) and negative MPO-ANCA. Serology for hepatitis B and C and tuberculosis was negative.

A review of the prior emergency department evaluation for his severe headaches revealed a computed tomography (CT) scan of his head that was positive for severe maxillary sinusitis, no acute intracranial hemorrhages/ischemia. A CT of his sinuses confirmed the involvement of the maxillary sinuses bilaterally, but no air fluid levels were noted. The frontal and ethmoidal sinuses were clear, and the ostiomeatal units were unremarkable.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

After rheumatology evaluation, treatment with high-dose oral steroids (prednisone 1 mg/kg daily) was initiated and patient was referred back to ENT for sinus biopsy. The pathology report was consistent with granulomatous vasculitis and necrosis involving sinonasal mucosa, revealing extensively inflamed and ulcerated sinonasal tissue with dense lymphoplasmacytic infiltrate and granulation tissue formation. Occasional profiles of medium-size arterioles show infiltration by lymphocytes and occasional giant cells (see Figures 1 and 2).

Figure 1. A nasal biopsy shows intimal infiltration of the small blood vessels (black arrow).

Figure 1. A nasal biopsy shows intimal infiltration of the small blood vessels (black arrow).

To evaluate disease extension, a CT of the chest was obtained. No hilar or mediastinal adenopathy, lung nodules or pleurisy were noted. An audiogram was also performed and was negative for hearing loss.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Based on these data, the disease was considered limited to upper airways. In addition to glucocorticoids, we initiated therapy with oral methotrexate. Clinically, the patient improved quickly. Constitutional symptoms completely resolved, as did the nasal congestion. His ear pain decreased, and his voice improved, along with his appetite and fatigue. Methotrexate was gradually increased over the course of the next three months from 10 mg to 20 mg weekly. The dose of prednisone was gradually tapered over the course of eight months. The patient was also prophylactically treated with trimethoprim/sulfamethoxazole (3x/week), weekly alendronate, daily calcium and vitamin D supplementation.

Three months after GPA diagnosis, his labs noted new-onset microscopic hematuria. A nephrology evaluation was obtained. A kidney biopsy was obtained, and fortunately it was negative for vasculitis changes. Shortly after, the patient was noted to have microscopic kidney stones.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Vasculitis Tagged with:ANCAanti-neutrophil cytoplasmic antibodies (ANCA)BiomarkersbiopsyGPAgranulomatosis with polyangiitis

Related Articles
    Figure 2: Renal Biopsy

    The Classification & Diagnosis of Granulomatosis with Polyangiitis

    August 16, 2018

    Based on the classification system developed by the Chapel Hill Consensus Conference, anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is defined as a necrotizing vasculitis involving small vessels that is associated with myeloperoxidase (MPO) ANCA or proteinase 3 (PR3) ANCA and displays minimal immune deposits. The mechanism behind the pathogenesis of ANCA-associated vasculitis is not fully…

    The Granulomatosis of Wegener’s

    May 16, 2011

    Delving deeper into the nonvasculitis aspects of the disease

    ACR Winter Rheumatology Symposium: Tips for ANCA Testing

    May 1, 2013

    How to select the correct testing method and interpret conflicting results from antineutrophil cytoplasmic antibody tests

    Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

    February 16, 2021

    Hydralazine has been in use as a treatment for hypertension, most notably in heart failure patients, since 1951.1 The drug is a known cause of autoimmune disease, most specifically hydralazine-induced lupus.  Hydralazine-induced lupus occurs in 7–13% of those taking the medication.2-4 It often presents with constitutional symptoms, arthritis/arthralgias, cutaneous lesions, sero­sitis, myalgias and/or hepatomegaly. Features…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences